Showing results (41-50 of 180) with videos related to

Sort By:
Pageof 18
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1998
[Diagnostic pitfalls in sulfonylurea-induced neuroglycopenic syndrome with hemiparesis, dysphasia and somnolence]A Holstein, H G Lankes, E H Egberts
European Journal of Clinical Pharmacology|April 17, 2003
Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemiaA Holstein, A Plaschke, C Hammer, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 7, 1999
Contra-indications to metformin therapy are largely disregardedA Holstein, D Nahrwold, S Hinze, et al.
Therapeutic Advances in Hematology|July 18, 2018
Update on the role of lenalidomide in patients with multiple myelomaSarah A Holstein, Vera J Suman, Philip L McCarthy
Current Hematologic Malignancy Reports|January 21, 2019
Should Overall Survival Remain an Endpoint for Multiple Myeloma Trials?Sarah A Holstein, Vera J Suman, Philip L McCarthy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2023
Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapy in Multiple Myeloma: Moving Into the FutureSarah A Holstein, Shakira J Grant, Tanya M Wildes
Scientific Reports|February 12, 2019
Modeling the Effects of Multiple Myeloma on Kidney FunctionJulia C Walk, Bruce P Ayati, Sarah A Holstein
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|March 2, 2002
Structural and process quality in the management of diabetic emergencies in GermanyA Holstein, A Plaschke, H Schlieker, et al.
Pageof 18